Romosozumab EVENITY™ (romosozumab injection) Romosozumab, a sclerostin inhibitor, is the first new approach to the treatment of osteoporosis and fracture risk in almost a decade.Romosozumab (EVENITY™) significantly and rapidly (over […]

Osteoporosis Canada continues to advise Canadians to meet the Institute of Medicine established daily calcium requirement of 1000 -1200 mg, from dietary sources preferably, and to use supplements if this […]

Bubl Fashion Feb 7th, 2019 Introducing a new collection from fashion designer, David Dixon, working in partnership with Osteoporosis Canada. LEARN MORE Living with the Disease Get valuable insight into […]

Vitamin D supplementation has recently been evaluated in Switzerland in a small 1 year randomized clinical trial by Bischoff-Ferrari and colleagues. This study compared the effects of two “high” doses […]

IMPACT REPORT 2019 – 2020 PATIENT STORY: MEET MURRAY BOLTON For Murray, it all started with a broken wrist. The kind of accident that could happen to anyone, he reasoned. […]

PRESS RELEASE TORONTO, November 19, 2020 – Dr. Earl Bogoch has been appointed the inaugural holder of the Brookfield Chair in Fracture Prevention. Dr. Famida Jiwa, President & CEO, Osteoporosis […]

A number of recent medical reports have linked high doses of intravenous bisphosphonates given to patients for the treatment of multiple myeloma, breast cancer or other cancers, to a condition […]

UPDATE As the COVID-19 situation and directives from public health agencies continue to evolve quickly, the Tamarack Ottawa Race Weekend and Scotiabank Ottawa Marathon have decided to temporarily pause new […]

Tools Algorithm 1 Integrated approach to the management of bone health and fracture prevention in postmenopausal females and males 50 years and older. DOWNLOAD Algorithm 2 Approach to pharmacotherapy to […]